Stocktoria
Ipsen S.A. IPN.PA
FR · Euronext Paris · XPAR · stock · Healthcare · website
Ipsen S.A. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €3.9B | €3.6B | €3.3B | €3.2B |
| Gross profit | €3.2B | €2.9B | €2.7B | €2.6B |
| R&D expense | €754.0M | €686.6M | €619.3M | €445.3M |
| SG&A expense | €1.2B | €1.1B | €1.1B | €1.0B |
| Operating income | €945.1M | €688.1M | €611.3M | €871.3M |
| Interest expense | €44.3M | €41.8M | €37.7M | €30.5M |
| Income tax | €133.6M | €74.9M | €136.2M | €112.3M |
| Net income | €443.5M | €345.9M | €644.4M | €648.6M |
| EPS (diluted) | €5.32 | €4.15 | €7.73 | €7.81 |
| Operating cash flow | €1.1B | €915.5M | €865.9M | €971.4M |
| Free cash flow | €809.7M | €133.0M | €677.0M | €718.5M |
| Cash & equivalents | €1.5B | €678.1M | €528.4M | €1.2B |
| Inventory | €240.9M | €285.5M | €289.5M | €284.1M |
| Goodwill | €633.8M | €699.5M | €663.9M | €579.9M |
| Total assets | €6.9B | €6.4B | €6.3B | €5.6B |
| Total debt | €867.1M | €426.8M | €373.5M | €613.3M |
| Total liabilities | €2.6B | €2.3B | €2.5B | €2.3B |
| Shareholders' equity | €4.3B | €4.2B | €3.8B | €3.3B |
| Share buybacks | €67.7M | €36.5M | €39.5M | €11.3M |
Growth · year-over-year · Revenue CAGR 7.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +9.9% | +8.1% | +4.7% | — |
| Net income growth | +28.2% | -46.3% | -0.6% | — |
| EPS growth | +28.2% | -46.3% | -1.0% | — |
| Free cash flow growth | +508.8% | -80.4% | -5.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · FR · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.